Stockreport

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 9.6%. Earnings per share (EPS) also missed analyst [Read more]